Abstract:Whether true memory T cells develop in the face of chronic infection such as tuberculosis remains controversial. To address this question, we studied CD8+ T cells specific for the Mycobacterium tuberculosis ESAT6-related Ags TB10.3 and TB10.4. The shared epitope TB10.3/10.420–28 is presented by H-2 Kd, and 20–30% of the CD8+ T cells in the lungs of chronically infected mice are specific for this Ag following respiratory infection with M. tuberculosis. These TB10.3/10.420–28-specific CD8+ T cells produce IFN-γ … Show more
“…Rapid accumulation of specific IFN-␥-secreting CD8 ϩ T cells is in line with previous observations of accelerated accumulation of CD8 ϩ T cells and early IFN-␥ production in tissues of vaccinated or infected and cured mice (13)(14)(15)18). At later time points after challenge, nonvaccinated mice showed similar numbers of specific IFN-␥ secreting CD8 ϩ T cells when compared with vaccinated mice.…”
Section: Discussionsupporting
confidence: 76%
“…After challenge infection, the secondary immune response in vaccinated mice or mice previously cured of M. tuberculosis infection is characterized by accelerated accumulation of effector T cells in infected tissues and early production of Th1 cytokines (12)(13)(14)(15)(16)(17)(18). Consequently, mycobacterial growth is restricted more efficiently in the initial phase of infection, and growth reaches a plateau at a 10-fold-lower level as compared with nonvaccinated animals.…”
“…Rapid accumulation of specific IFN-␥-secreting CD8 ϩ T cells is in line with previous observations of accelerated accumulation of CD8 ϩ T cells and early IFN-␥ production in tissues of vaccinated or infected and cured mice (13)(14)(15)18). At later time points after challenge, nonvaccinated mice showed similar numbers of specific IFN-␥ secreting CD8 ϩ T cells when compared with vaccinated mice.…”
Section: Discussionsupporting
confidence: 76%
“…After challenge infection, the secondary immune response in vaccinated mice or mice previously cured of M. tuberculosis infection is characterized by accelerated accumulation of effector T cells in infected tissues and early production of Th1 cytokines (12)(13)(14)(15)(16)(17)(18). Consequently, mycobacterial growth is restricted more efficiently in the initial phase of infection, and growth reaches a plateau at a 10-fold-lower level as compared with nonvaccinated animals.…”
“…CD8 + T cells have an essential but underappreciated role in the control of TB (12) and are critical for both natural and vaccine-induced immunity in nonhuman primates (NHPs) (13,14). In contrast, the role of B cells in immunity to TB is less well understood, although it appears they are required for the development of optimal immune responses to Mtb via various regulatory mechanisms (15)(16)(17).…”
Section: Nonhuman Primate | B Cells | Tuberculosis | Cd4 T Cells | CDmentioning
The synergy between Mycobacterium tuberculosis (Mtb) and HIV in coinfected patients has profoundly impacted global mortality because of tuberculosis (TB) and AIDS. HIV significantly increases rates of reactivation of latent TB infection (LTBI) to active disease, with the decline in CD4 + T cells believed to be the major causality. In this study, nonhuman primates were coinfected with Mtb and simian immunodeficiency virus (SIV), recapitulating human coinfection. A majority of animals exhibited rapid reactivation of Mtb replication, progressing to disseminated TB and increased SIV-associated pathology. Although a severe loss of pulmonary CD4 + T cells was observed in all coinfected macaques, a subpopulation of the animals was still able to prevent reactivation and maintain LTBI. Investigation of pulmonary immune responses and pathology in this cohort demonstrated that increased CD8 + memory T-cell proliferation, higher granzyme B production, and expanded B-cell follicles correlated with protection from reactivation. Our findings reveal mechanisms that control SIV-and TB-associated pathology. These CD4-independent protective immune responses warrant further studies in HIV coinfected humans able to control their TB infection. Moreover, these findings will provide insight into natural immunity to Mtb and will guide development of novel vaccine strategies and immunotherapies.Nonhuman primate | B cells | tuberculosis | CD4 T cells | CD8 T cells
“…a lower proportion of IFN-␥-expressing cells (31.3% of Gagtetramer ϩ CD11a ϩ CD8 ϩ T cells were IFN-␥ ϩ ; data not shown). Some other studies of cytokine expression by Ag-specific CD8 ϩ T cells in peripheral mucosal tissues have also shown modest levels of expression (42,43).…”
Most HIV infections result from heterosexual transmission to women. Because cellular immunity plays a key role in the control of the infection, we sought to strengthen cellular immune responses in vaginal tissue. We explored a novel prime-boost protocol that used two live mucosal agents that trigger different pathways of innate immunity and induce strong cellular immunity. Adenovirus serotype 5 (Ad5) has frequently been used as a boost for DNA vaccines. In this study we used attenuated, recombinant L. monocytogenes-gag (rLm-gag) to prime mice by various mucosal routes—oral, intrarectal, and intravaginally (ivag)—followed by a systemic or mucosal boost with replication-defective rAd5-gag. Mice primed with a single administration of rLm-gag by any route and then boosted with rAd5-gag intramuscularly exhibited abundant Gag-specific CD8 T cells in spleen and vaginal lamina propria. Conversely, when boosted with rAd5-gag ivag, the immune response was reoriented toward the vagina with strikingly higher CD8 T cell responses in that tissue, particularly after ivag immunization by both vectors (ivag/ivag). Five weeks to 5 mo later, ivag/ivag-immunized mice continued to show high levels of effector memory CD8 T cells in vagina, while the pool of memory T cells in spleen assumed a progressively more central memory T cell phenotype. The memory mice showed high in vivo CTL activity in vagina, a strong recall response, and robust protection after ivag vaccinia-gag challenge, suggesting that this prime-boost strategy can induce strong cellular immunity, especially in vaginal tissues, and might be able to block the heterosexual transmission of HIV-1 at the vaginal mucosa.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.